Friday, November 22, 2024
Lawyers Run The WorldUsing Garcinia Science to Substantiate Claims and Enhance Conversions

Using Garcinia Science to Substantiate Claims and Enhance Conversions

-

- Advertisment -spot_img

Dietary supplements, herbal remedies, patches, creams, wraps and products rubbed into the skin are high-profile. Weight loss offers are among the most intensely scrutinized by local, state and federal regulators.

Each website must be in substantial compliance based on the specific facts and nature of the advertising program.

Issues such as claim substantiation and “competent and reliable scientific evidence,” endorsements and testimonials, before and after photos, negative option programs and third party intellectual property all must be critically considered.

This article briefly considers substantiating express and implied claims in relation to a garcinia product’s daily dosages of the compound hydroxycitric acid (“HCA”). In other words, query whether the daily intake of HCA considered in relevant “randomized and controlled human clinical trials” (“RCTs”) is substantially similar to that which might be recommended to achieve the results expressed in ad copy.

It is risky business to assume that merely finding studies testing the same substance necessarily constitutes adequate evidence to substantiate each efficacy claim.

Ideally, locating “competent and reliable scientific evidence” (“CRSE”) should be located first, prior to building scientifically sound ad copy. Building ad copy first and then trying to find independent tests to fit within previously made representations is a recipe for disaster.

Simply stated, if you make an express or implied representation that your product causes weight loss, the claim cannot be misleading and you must have CRSE that substantiates that the representation is true.

What do your RCTs really show?

When evaluating RCTs, always consider issues such as, without limitation, the length of the study, whether the clinical results are robust and significant, whether the study is published in a peer-reviewed journal, and, of course, the test subjects, dose, dosage form, route of administration, formulation, total length of exposure, frequency of exposure, study population and results.

If you are marketing a garcinia product, you must be extremely careful if you intend to use RCTs that do not match your product exactly in terms of dosage. Doing so will leave you vulnerable to claims of deceptive advertising for giving an unsupported message.

Literature associated with human studies of garcinia and weight loss is mixed, with interpretation complicated by diverse population inclusions and inconsistent clinical study designs. Nevertheless, positive and statistically significant garcinia-supportive data is contained within a handful of properly conducted studies and reviews.

If properly analyzed and implemented by an experienced weight loss product and nutraceutical advertising compliance lawyer, qualifying RCTs and related data on the use of the garcinia extract HCA as a weight-loss supplement can be utilized to support express and implied efficacy claims. Moreover, those same RCTs and the data contained therein can be applied in such a manner that may safely optimize conversions.

RCTs clearly establish that fat mass and weight decreases are all dependent upon a variety of factors, including HCA dosage. If your RCTs have positive findings based upon, for example, a dosage of HCA ranging from 1 g to 2.8 g daily, your product formulation and daily HCA intake instructions must be consistent. Otherwise, absent “clear and conspicuous” disclosures, all the CRSE and RCTs in the world will not help you to avoid a deceptive advertising claim.

While not linear, some existing data and sophisticating imaging methodologies do suggest that increased daily HCA dosage may be associated with fat reduction and/or increased weight loss. Your CRSE and related representations will necessarily depend upon your product formulation and, perhaps the preparation or extraction of HCA.

Clinical observations, limitations and considerations set forth in available scientific literature with respect to the antiobesity effect and biochemical effectiveness of HCA should be critically examined and used to your advantage prior to launching a garcinia cambogia advertising campaign.

Please contact the author at via email at rnewman@hinchnewman.com if you would like to learn more about weight loss advertising compliance considerations.

HINCH NEWMAN LLP. ADVERTISING MATERIAL. These materials are provided for informational purposes only and are not to be considered legal advice, nor do they create a lawyer-client relationship. No person should act or rely on any information in this article without seeking the advice of an attorney. Information on previous case results does not guarantee a similar future result.

Richard B. Newman
Richard B. Newmanhttp://www.hinchnewman.com
Richard B. Newman is an Internet Lawyer at Hinch Newman LLP focusing on advertising law, Internet marketing compliance, regulatory defense and digital media matters. His practice involves conducting legal compliance reviews of advertising campaigns across all media channels, regularly representing clients in high-profile investigative proceedings and enforcement actions brought by the Federal Trade Commission and state attorneys general throughout the country, advertising and marketing litigation, advising on email and telemarketing best practice protocol implementation, counseling on eCommerce guidelines and promotional marketing programs, and negotiating and drafting legal agreements.

What's your opinion?

Latest news

Disney Gets Dirty: Playing in Programmatic’s Muddy Waters

Once upon a time, Disney stood as the epitome of wholesome family entertainment. But now, the House of Mouse...

The Trade Desk’s Ventura: Shaking Up CTV or Just Stirring the Pot?

Connected TV (CTV) just got a wake-up call—or maybe a Molotov cocktail. The Trade Desk has announced Ventura, its new...

From Big Ideas to Tiny Banners: How #Adtech Shrinks the Dream

When I resurrected this newsletter from the ashes of my previous endeavor—dusted it off like some overambitious Frankenstein experiment—I...

The Ad Tech Racket: How The Trade Desk is Taxing Your Campaigns Into Oblivion

Let’s talk about The Trade Desk (TTD) and their latest contribution to the world of advertising—what can only be...

PubMatic Bets Big on Elon’s X: Bold Innovation or PR Suicide?

PubMatic has officially stepped into the lion’s den, announcing its partnership with Elon Musk’s X (formerly Twitter) as its...

The AdTech Wizard of Odds: Gareth Holmes on Streaming Ads, Helicopters, and Unleashing Sweden’s Secret Sauce 

Adtech is often described as a wild west, but Gareth Holmes makes it sound more like Cirque du Soleil—complete...

Must read

The Trade Desk’s Ventura: Shaking Up CTV or Just Stirring the Pot?

Connected TV (CTV) just got a wake-up call—or maybe...

From Big Ideas to Tiny Banners: How #Adtech Shrinks the Dream

When I resurrected this newsletter from the ashes of...

You might also likeRELATED
Recommended to you